Brokers say these ASX 100 shares are buys right now

These high-quality shares could be just what your portfolio needs.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While the ASX 100 index may not be as well-known or widely followed as the benchmark ASX 200 index, what it lacks in attention it makes up for in quality.

Among the 100 companies included in the index are some of the biggest and brightest that Australia has to offer. But which ASX 100 shares are buys?

Two that could be worth considering according to analysts are listed below. Here's why they rate these ASX 100 shares as buys:

A young investor working on his ASX shares portfolio on his laptop.

Image source: Getty Images

Cochlear Limited (ASX: COH)

The first ASX 100 share that could be a buy is Cochlear.

It is a leading manufacturer and distributor of cochlear implantable devices for hearing impaired globally. It offers three main products: Cochlear implants, Baha bone conduction implants, and Cochlear Wireless Accessories.

Goldman Sachs believes Cochlear would be a top option for investors right now. Particularly given that trading conditions have improved materially now COVID headwinds are easing. It said:

Looking forward, we continue to express a general preference for the device/drug names over the service providers in the current environment, on the basis of: i) stronger pricing power; ii) more assured volume profiles; iii) more resilient/expanding market shares; and iv) stronger balance sheets.

We believe Cochlear screens well on these fundamental factors, and largely avoids the margin uncertainties prevalent across other verticals. We expect a sequential improvement in momentum through 2H23 (further elective volume improvement and new processor launch momentum, potentially tempered by some moderation in Acoustics). We forecast above guidance in FY23E (GSe: $306m vs. $290-305m) and believe shares will now be further supported by a newly announced multi-year buyback program (GSe: $75m/year).

Its analysts currently have a buy rating and $265.00 price target on its shares.

Seek Ltd (ASX: SEK)

Another ASX 100 share that could be a buy is Seek.

It operates an online employment classifieds platform across 12 countries. It has three main business segments: SEEK Employment, SEEK Learning, and SEEK International.

Morgans is positive on the company. Its analysts believe Seek will benefit from a number of tailwinds that lead to increased reliance on the company's products and services. It explains:

Of the classifieds players, we continue to see SEEK as the one with the most relative upside, a view that's based on the sustained listings growth we've seen over the period. The tailwinds that have driven elevated job ads (~210k currently, broadly flat on the robust pcp) and strong FY22 result appear to still remain in place, i.e. subdued migration, candidate scarcity and the drive for greater employee flexibility. With businesses looking to grow headcount in the coming months and job mobility at historically high levels according to the RBA, we see these favourable operating conditions driving increased reliance on SEEK's products.

Morgans has an add and $28.40 price target on Seek's shares.

Motley Fool contributor James Mickleboro has positions in Seek. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear and Seek. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Broker Notes

3 ASX shares upgraded by Morgans to buy ratings

Let's see why the broker has turned positive on these shares.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Wooden blocks spelling rebound with coins on top.
Broker Notes

Can Life360 shares recover from the AI fuelled sell-off?

A leading expert looks into the AI-driven pressure hitting Life360 shares.

Read more »

An engineer takes a break on a staircase and looks out over a huge open pit coal mine as the sun rises in the background.
Broker Notes

Up 49% in a year, should you buy BHP shares for their 'stability and income'?

A leading expert delivers his forecast for BHP’s fast-rising shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Pro Medicus, Life360, A2 Milk shares

Expert analysts reveal their latest recommendations on 3 ASX 200 stocks.

Read more »

A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
Broker Notes

Buy, hold, sell: Goodman Group, BHP, Westpac shares

ASX 200 shares are in the red for a fifth consecutive session amid stalled peace talks between the US and…

Read more »

Business man marking Sell on board and underlining it
Broker Notes

Experts name 3 ASX 200 shares to sell now

Let's see which shares are being tipped as sells this week.

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Broker Notes

What is Morgans' updated view on Bank of Queensland and PLS shares?

These ASX 200 stocks are performing very differently this year.

Read more »